India Lapses Test Relationship But Let’s Listen And Learn: U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
In their latest trip to India, senior U.S. FDA officials mulled several new ideas including a rating system for drug companies, noting that the main aims of the visit were to “listen and learn” and draw up programs that benefit patients in both countries.